ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | |
| 96.3% | 96.3% | 96.6% | 95.9% | 95.5% | 95.3% | 88.9% | 89.8% | 93.2% | – | 90.0% | 100.0% | |
| 95.1% | 94.3% | 91.9% | 92.0% | 92.3% | 92.2% | 71.7% | 75.8% | 82.7% | – | 74.8% | 97.7% | |
| 95.1% | 94.3% | 91.9% | 92.0% | 92.3% | 92.2% | 71.7% | 75.8% | 82.7% | – | 74.8% | 97.7% | |
| 40.4% | 50.4% | 73.2% | 94.5% | 118.5% | 150.5% | 326.3% | 410.3% | 431.8% | – | 189.2% | 26.8% | |
| 17.2% | 22.1% | 44.0% | 59.2% | 80.7% | 109.3% | 270.3% | 354.6% | 388.4% | – | 189.2% | 26.8% | |
| 1.2% | 1.5% | 1.5% | 5.5% | 12.0% | 22.2% | 30.6% | 46.2% | 51.9% | – | – | – | |
| 4.5% | 3.1% | 6.7% | 5.9% | 5.9% | 14.3% | 33.8% | 52.1% | 51.9% | – | 35.6% | 4.8% | |
| 59.6% | 49.6% | 26.8% | 5.5% | -18.5% | -50.5% | -226.3% | -310.3% | -331.8% | – | -89.2% | 73.2% | |
| -408.5% | -528.0% | -573.0% | -791.0% | -997.3% | -1,299.0% | -3,897.5% | -4,754.9% | -4,775.8% | – | -3,579.1% | -487.2% | |
| 0.4% | 0.4% | 0.5% | 0.6% | 0.7% | 0.9% | 2.7% | 3.4% | 4.1% | – | 51.5% | 10.7% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.